Consider reescalation to 2.4 mg once weekly [see Adverse Reactions (6.1), Clinical Studies (14.4)]
Ascendis, Ascendis Pharma, the Ascendis Pharma logo, the company logo, and TransCon are trademarks owned by the Ascendis Pharma group
Potential Therapeutic Benefit in Stroke Recovery: A study demonstrated that Delta Sleep-Inducing Peptide might have potential therapeutic benefits in stroke therapy, specifically in accelerating the recovery of motor functions after a stroke (9)
For example, certain anti-inflammatory creams or antihistamines might help reduce skin reactions
Feedback regulation of insulin secretion by extended synaptotagmin-1
Klinic Accepts Insurance and Handles Prior Authorization Navigating insurance coverage is often a significant hurdle in starting weight loss medication